Current topical and systemic approaches to treatment of rosacea

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 8, 2009, Pages 876-882

  Korting, H C ^a   Schollmann C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Azelaic acid; Doxycycline; Metronidazole; Rosacea

Indexed keywords

AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; OXYTETRACYCLINE; PERMETHRIN; RETINOIC ACID; SULFACETAMIDE; TACROLIMUS; TETRACYCLINE;

ANTIINFLAMMATORY ACTIVITY; CONTACT DERMATITIS; CONTROLLED RELEASE FORMULATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FACE DEFORMITY; FIBROMA; GENETIC PREDISPOSITION; HUMAN; LOW DRUG DOSE; OPTIMAL DRUG DOSE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PRURITUS; REMISSION; REVIEW; RISK FACTOR; ROSACEA; SKIN CARE; SKIN DISEASE; TREATMENT RESPONSE; XEROSIS;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DOXYCYCLINE; DRUG THERAPY, COMBINATION; HUMANS; METRONIDAZOLE; ROSACEA;

EID: 67651174651     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03167.x     Document Type: Review

References (58)

1. Blount BW, Pelletier AP. Rosacea: a common yet commonly overlooked condition. Am Fam Physician 2002 66 : 435 440, 442.
2. Eiseman AS. The ocular manifestations of atopic dermatitis and rosacea. Curr Allergy Asthma Rep 2006 6 : 292 298.
3. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989 69 : 419 423.
4. Kligman AM. A personal critique on the state of knowledge of rosacea. Dermatology 2004, 2008 : 191 198.
5. Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelides S, Michailides C, Pagana G. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005 53 : 918 919.
6. Del Rosso JQ, Webster GF, Kackson M et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007 56 : 791 802.
7. Feldman SR, Hollar CB, Gupta AK, Fleischer AB Jr. Women commonly seek care for rosacea: dermatologists frequently provide the care. Cutis 2001 68 : 156 160.
8. Berg M. Facial skin complaints and work at visual display units. Epidemiological, clinical and histopathological studies. Acta Derm Venereol 1989 150 : 1 40.
9. Guttman C. Rosacea prevalence underestimated [WWW document] 2006. URL: http://www.modernmedicine.com/modernmedicine/Clinical+Dermatology/ Rosacea-prevalence-underestimated/ArticleStandardArticle/detail/383156 (last accessed 23 May 2009).
10. Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007 12 : 1 5.
11. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed 2003 2 : 43 47.
12. Bikowski J. Examining inflammation as a common factor in theories of rosacea pathophysiology [WWW document] 2008. URL http://www.rosaceatoday.com/ TheoriesofRosacea.asp (last accessed 5 May 2009).
13. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004 51 : 499 512.
14. Wilkin J, Dahl M, Detmar M et al. 1. Standard classification of rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2002 46 : 584 587.
15. Wilkin J, Dahl M, Detmar M et al. National rosacea society expert committee on the classification and staging of rosacea. Standard grading system for rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol 2004 50 : 907 912.
16. Taub AF. Treatment of rosacea with intense pulsed light. J Drugs Dermatol 2003 2 : 254 259.
17. Butterwick KJ, Butterwick LS, Han A. Laser and light therapies for acne rosacea. J Drugs Dermatol 2006 5 : 35 39.
18. Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998 134 : 884 885.
19. Sanchez J, Somolinos AL, Almodovar PI, Webster G, Bradshaw M, Powala C. A randomized, double-blind placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 2005 53 : 791 797.
20. Fowler JF Jr. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 2007 6 : 641 645.
21. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytretracycline therapy for rosacea. Br J Dermatol 1983 109 : 63 65.
22. Wolf JE Jr., Del Rosso JQ. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis 2007 79 : 73 80.
23. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001 45 : 723 730.
24. Yoo Y, Reid DC, Kimball AB. Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter? J Drugs Dermatol 2006 5 : 317 319.
25. Van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol 2007 56 : 107 115.
26. Beutner KR, Lemke S, Calvarese B. A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential. Cutis 2006 77 : 12 17.
27. Maddin A. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999 40 : 961 965.
28. Elewski BE, Fleischer AB Jr., Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 2003 139 : 1444 1450.
29. Wolf JE Jr., Kerrouche N, Arsonnaud S. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azalaic acid 15% gel in the treatment of rosacea. Cutis 2006 77 : 3 11.
30. Veien NK, Christiansen JV, Hjorth N, Schmidt H. Topical metronidazole in the treatment of rosacea. Cutis 1986 38 : 209 210.
31. Ozturkcan Ş, Ermertcan AT, Sahin MT, Afsar FŞ. Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol 2004 31 : 610 617. (Pubitemid 39243783)
32. Koçak M, Yaĝli S, Vahapoĝlu G, Ekşioĝlu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 2002 205 : 265 270.
33. Sauder DN, Miller R, Gratton D, Danby W, Griffiths C, Phillips SB. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatolog Treat 1997 8 : 79 85.
34. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis 2002 70 : 271 275.
35. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991 41 : 780 798.
36. Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003 48 : 836 845.
37. Carmichael AJ, Marks R, Graupe KA, Zaumseil RP. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat 1993 4 (Suppl. 1 S19 S22.
38. Woo DK, James WD. Topical tacrolimus: a review of its uses in dermatology. Dermatitis 2005 16 : 6 21, 2005.
39. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001 44 : 995 998.
40. Bergman J, Rico MJ. Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg 2001 20 : 250 259.
41. Kligman AM. Topical tretinoin for rosacea: a preliminary report. J Dermatol Treat 1993 4 : 71 73.
42. Kligman AM, Dogadkina D, Lavker RM. Effects of topical tretinoin on non-sunexposed protected skin of the elderly. J Am Acad Dermatol 1993 29 : 25 33.
43. Vienne MP, Ochando N, Borrel MT, Gall Y, Lauze C, Dupuy P. Retinaldehyde alleviates rosacea. Dermatology 1999 199 : 53 56.
44. Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol 1966 78 : 649 652.
45. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother 2004 5 : 5 13.
46. Bikowski JB, Goldman MP. Rosacea: where are we now? J Drugs Dermatol 2004 3 : 251 261.
47. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006 54 : 258 265.
48. Maibach H. Second generation tetracyclines, a dermatological overview: clinical uses and pharmacology. Cutis 1991 48 : 411 417.
49. Berman B, Perez OA, Zell D. Update on rosacea and anti-inflammatory-dose doxycycline. Drugs Today (Barcelona) 2007 43 : 27 34.
50. Theobald K, Bradshaw M, Leyden J. Anti-inflammatory doxycycline (40 mg contolled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed 2007 6 : 221 226.
51. Walker C, Puumala S, Golub LM, Stoner JA, Lee HM, Payne JB. Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbial results. J Periodontol 2007 78 : 1590 1601.
52. Torresani C. Clarithromycin: a new perspective in rosacea treatment. Int J Dermatol 1998 37 : 343 349.
53. Torresani C, Pavesi A, Manata GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 1997 36 : 938 946.
54. Bakar O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004 43 : 151, 2004.
55. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994 130 : 319 324.
56. Pye RJ, Burton JL. Treatment of rosacea by metronidazole. Lancet 1976 1 : 1211 1212.
57. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol 1980 102 : 443 445.
58. Wienbren MJ, Perinpanayagam RM, Camba L, Lee CA. Convulsions and encephalopathy in a patient with leukaemia after treatment with metronidazole. J Clin Pathol 1985 38.